Sort
15,842 grants matching “pancreatic cancer”
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$493,726Mark R. Kelley · Indiana University Indianapolis · R01 · FY2018 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$493,726Mark R. Kelley · Indiana University Indianapolis · R01 · FY2021 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$493,726Mark R. Kelley · Indiana University Indianapolis · R01 · FY2020 · CA
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution
$493,689Dana M Spence · Michigan State University · R01 · FY2024 · HL
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
$493,658Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2021 · CA
Protein Structure, Stability, and Amyloid Formation
$493,654Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development and Implementation of ElectronicDecision Aids for Genetic Testing in Inherited Cancer Syndromes
$493,563Daniel C Chung · Massachusetts General Hospital · U01 · FY2024 · CA
Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers
$493,493Neelam Tyagi · Sloan-Kettering Inst Can Research · R01 · FY2024 · EB
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$493,411Eric T. Kool · Stanford University · R01 · FY2020 · CA
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
$493,395Peter J Allen · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
TASK ORDER: FURTHER TESTING OF A MULTI-PEPTIDE KRAS VACCINE FOR PANCREATIC CANCER PREVENTION
$493,001Venkateshwar Chinthalapally · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA
Clinical Studies of Circulating Epithelial Cancer Cells
$492,960Ccc Diagnostics, Llc · R44 · FY2005 · CA
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light
$492,918Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2021 · EB
Mechanisms of Epigenetic Plasticity in PDAC
$492,890Chunling Yi · Georgetown University · R01 · FY2025 · CA
The role of regulator of G protein signaling Gbeta5-R7 in neuronal control of body weight
$492,777Vladlen Z Slepak · University Of Miami School Of Medicine · R01 · FY2023 · DK
Proliferation and Differentiation of Bladder Epithelial Cells in Regeneration and Malignancy
$492,746Philip A Beachy · Stanford University · R01 · FY2019 · CA
3D carbon-nanotubes integrated microdevice for extracellular vesicle isolation and in situ sample preparation towards noninvasive pancreatic cancer diagnosis
$492,651Siyang Zheng · Carnegie-Mellon University · R01 · FY2021 · CA
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
$492,648Eric Hollander · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · FD
Glutamine synthetase in beta-catenin driven hepatocellular carcinoma
$492,434Wei-Xing Zong · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
$492,416Edgar G. Engleman · Stanford University · U01 · FY2010 · CA
Establishment and regulation of the immune suppressive microenvironment in pancreatic cancer
$492,287Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$492,233Davendra Sohal · University Of Cincinnati · R01 · FY2023 · FD
Glutamine synthetase in beta-catenin driven hepatocellular carcinoma
$492,130Wei-Xing Zong · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Treatment of Hypoxia Resistance in Pancreatic Cancer - Clinical
$491,953Tomislav Dragovich · Translational Genomics Research Inst · P01 · FY2008 · CA
Linear energy transfer (LET) dependencies for understanding pancreatic tumor control and relevant molecular endpoints in support of RBE-based heavy-ion radiotherapy
$491,745Sally A. Amundson · Columbia University Health Sciences · R01 · FY2024 · CA